Target intelligence / Profile preview

Novel transcript, antisense to propionyl-CoA carboxylase subunit alpha (ENSG00000287330)

Target
ENSG00000287330
Molecular classification
Long non-coding RNA, Antisense lncRNA
01

Overview

ENSG00000287330 is an antisense long non-coding RNA transcript situated opposite the protein-coding PCCA gene locus (Propionyl-CoA carboxylase subunit alpha). It is classified as an antisense lncRNA, typically involved in the regulation of its sense gene by various transcriptional and post-transcriptional mechanisms such as promoter methylation, transcription interference, or splicing modulation. There is currently no evidence that this transcript codes for a protein, is a classical drug target, or is directly implicated in disease or therapy. No interacting drugs, biomarkers, or disease role have been documented. Its primary importance may be as a putative regulator of PCCA gene expression, but comprehensive functional studies or disease links are not available. Based on the above, ENSG00000287330 is not recognized as a standard therapeutic target, and the target’s designation is likely to be incorrect for the purposes of drug development or therapeutic targeting. The entry does not include a canonical abbreviation or established aliases in biomedical literature; it should be classified as a long non-coding antisense RNA with provisional regulatory functions, but little additional characterization exists.

Other names
novel transcript, antisense to PCCAENSG00000287330
02

Mechanism of action

Not established; general mechanisms of antisense lncRNAs include transcriptional and post-transcriptional regulation of their sense strand gene (e.g., PCCA).

03

Biological functions

Regulates the expression and function of the complementary protein-coding locus (PCCA) through possible cis-regulatory mechanisms such as promoter methylation, transcriptional interference, splicing regulation, and RNA stability, as described for antisense lncRNAs generallyPutative regulator of PCCA gene expression
04

Disease associations

Not established; antisense lncRNAs can play roles in genetic, metabolic, or immune regulation, but no disease implication has been described for this specific transcript
05

Safety considerations

None known; targeting non-coding RNAs may present off-target effects and delivery challenges in a therapeutic context, but no data exist for this transcript.

Beyond the preview

Go deeper on Novel transcript, antisense to propionyl-CoA carboxylase subunit alpha (ENSG00000287330).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to propionyl-CoA carboxylase subunit alpha (ENSG00000287330).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call